key: cord-0707317-9hjq1452
authors: Balconi, Sindy N.; Lopes, Natane T.; Luzzatto, Laura; Bonamigo, Renan R.
title: Detection of SARS‐CoV‐2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?
date: 2020-11-24
journal: Int J Dermatol
DOI: 10.1111/ijd.15316
sha: 28fe06beb06476d365a23302d7fccd55472a625c
doc_id: 707317
cord_uid: 9hjq1452

nan

Dear Editor, Drug reaction with eosinophilia and systemic symptoms (DRESS) is a hypersensitivity syndrome that includes severe skin rash, fever, lymphadenopathy, hematologic changes with eosinophilia, atypical lymphocytes, and possible involvement of other organs, such as liver and kidneys. 1 It's a potentially lifethreatening condition that usually appears within 2 months of initiation of a new drug. 1, 2 Diagnosis relies on clinical and laboratory findings and on use of the RegiSCAR scoring system. 1, 2 There is evidence that the disease occurs in genetically predisposed people after ingestion of a related drug, such as sulfonamides. 2 Reactivation of some viruses and the immunological response that follows it are involved mechanisms. 2 We report a case of DRESS associated with COVID-19.

A 20-year-old woman presented to the emergency department with a morbilliform, erythematous-violaceous rash, fever Blood tests showed significant leukocytosis (28,020/ll), lymphocytosis (9,807/ll), 13% of atypical lymphocytes, eosinophilia (2,522/ll), elevated lactate dehydrogenase (1,378 U/l), and elevated erythrocyte sedimentation rate, C-reactive protein, and Ddimers (1,440 ng/ml). Transaminase levels were elevated to 7fold the upper limit of normal (ALT 403 iU/l and AST 350 iU/l).

Antinuclear antibodies, blood cultures, and serologic test results for HIV, HCV, HBV, toxoplasmosis, syphilis, CMV, and EBV were negative. Histopathology of the rash revealed spongiosis, intense vacuolar degeneration of the basal layer and lymphoid infiltrate in the dermo-epidermal interface, and presence of rare eosinophils, without vasculitis (Fig 1) . Based on clinical, laboratory, and histopathologic features and a RegiSCAR score >5, both DRESS and COVID-19 were diagnosed.

Numerous skin rashes have been reported in SARS-CoV-2 infection. 3 In the present case, the patient had concurrent diagnoses of DRESS and COVID-19. Supportive and corticosteroid therapy was performed, and she recovered and was dis- 

Recent advances in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system

Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue

Virus Reactivation in drug reaction with eosinophilia and systemic symptoms (Dress) results from a strong drug-specific immune response

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anticytokine interventions

Funding source: None. doi: 10.1111/ijd.15316